IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850,077 | -44.3% | 116,577 | -33.8% | 1.17% | -41.7% |
| Q2 2023 | $3,321,875 | +242.5% | 176,040 | -30.3% | 2.01% | +202.6% |
| Q1 2023 | $969,800 | -29.8% | 252,552 | -9.4% | 0.66% | -30.3% |
| Q4 2022 | $1,381,990 | +21.3% | 278,627 | +16.9% | 0.95% | -18.1% |
| Q3 2022 | $1,139,000 | +6.7% | 238,302 | +0.5% | 1.16% | +66.4% |
| Q2 2022 | $1,067,000 | -1.1% | 237,202 | +4.7% | 0.70% | +37.0% |
| Q1 2022 | $1,079,000 | -29.6% | 226,602 | +9.7% | 0.51% | -23.6% |
| Q4 2021 | $1,533,000 | +42.5% | 206,652 | +8.9% | 0.67% | +31.2% |
| Q3 2021 | $1,076,000 | -17.1% | 189,702 | -3.7% | 0.51% | -15.1% |
| Q2 2021 | $1,298,000 | -16.6% | 197,002 | +1.7% | 0.60% | -23.0% |
| Q1 2021 | $1,557,000 | -0.4% | 193,755 | -20.7% | 0.78% | -8.2% |
| Q4 2020 | $1,564,000 | – | 244,421 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |